What Is the Future of Neoantigen Vaccines in Cancer Treatment?
The future of neoantigen vaccines is promising, with ongoing advancements in genomic technologies and bioinformatics. As these technologies improve, the process of identifying and manufacturing personalized vaccines will become more efficient and cost-effective. Furthermore, as more clinical trials yield positive results, neoantigen vaccines could become a standard component of personalized cancer treatment.
